Skip to main content

Advertisement

SpringerLink
Log in

Postpartum anemia II: prevention and treatment

  • Review Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

This review focuses on the prevention and treatment of anemia in women who have just given childbirth (postpartum anemia). The problem of anemia both prepartum and postpartum is far more prevalent in developing countries than in the Western societies. The conditions for mother and child in the postpartum, nursing, and lactation period should be as favorable as possible. Many young mothers have a troublesome life due to iron deficiency and iron deficiency anemia (IDA) causing a plethora of symptoms including fatigue, physical disability, cognitive problems, and psychiatric disorders. Routine screening for postpartum anemia should be considered as part of the national maternal health programs. Major causes of postpartum anemia are prepartum iron deficiency and IDA in combination with excessive blood losses at delivery. Postpartum anemia should be defined as a hemoglobin level of <110 g/l at 1 week postpartum and <120 g/l at 8 weeks postpartum. Bleeding exceeding normal blood losses of approximately 300 ml may lead to rapid depletion of body iron reserves and may, unless treated, elicit long-standing iron deficiency and IDA in the postpartum period. The prophylaxis of postpartum anemia should begin already in early pregnancy in order to ensure a good iron status prior to delivery. The most reliable way to obtain this goal is to give prophylactic oral ferrous iron supplements 30–50 mg daily from early pregnancy and take obstetric precautions in pregnancies at risk for complications. In the treatment of slight-to-moderate postpartum IDA, the first choice should be oral ferrous iron 100 to 200 mg daily; it is essential to analyze hemoglobin after approximately 2 weeks in order to check whether treatment works. In severe IDA, intravenous ferric iron in doses ranging from 800 to 1,500 mg should be considered as first choice. In a few women with severe anemia and blunted erythropoiesis due to infection and/or inflammation, additional recombinant human erythropoietin may be considered. Blood transfusion should be restricted to women who develop circulatory instability due to postpartum hemorrhage. National health authorities should establish guidelines to combat iron deficiency in pregnancy and postpartum in order to facilitate a prosperous future for both mothers and children in a continuing globalized world.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Milman N (2011) Postpartum anemia I: definition, prevalence, causes and consequences. Ann Hematol 90:1247–1253

    Article  PubMed  Google Scholar 

  2. Milman N. Anemia—still a major health problem in many parts of the world! Ann Hematol 2011; 90:369–377. http://dx.doi.org/10.1007/s00277-010-1144-5

  3. World Health Organization (1999) Reduction of maternal mortality. A joint WHO/UNFPA/UNICEF/World Bank statement. World Health Organization, Geneva

    Google Scholar 

  4. Potts M, Campbell M (2004) Three meetings and fewer funerals: misoprostol in postpartum hemorrhage. Lancet 364:1110–1111

    Article  PubMed  Google Scholar 

  5. Tsu VD, Shane B (2004) New and underutilized technologies to reduce maternal mortality: call to action from a Bellagio workshop. Int J Gynecol Obstet 85(Suppl 1):S83–S93

    Article  Google Scholar 

  6. Bodnar LM, Siega-Riz AM, Miller WC, Cogswell ME, McDonald T (2002) Who should be screened for postpartum anemia? An evaluation of current recommendations. Am J Epidemiol 156:903–912

    Article  PubMed  Google Scholar 

  7. Bergmann RL, Richter R, Bergmann KE, Dudenhausen JW (2010) Prevalence and risk factors for early postpartum anemia. Eur J Obstet Gynecol Reprod Biol 150:126–131

    Article  PubMed  Google Scholar 

  8. Milman N, Kirchhoff M (1992) Iron stores in 1359, 30- to 60-year-old Danish women: evaluation by serum ferritin and hemoglobin. Ann Hematol 64:22–227

    Article  PubMed  CAS  Google Scholar 

  9. Milman N (2008) Prepartum anaemia: prevention and treatment. Ann Hematol 87:949–959

    Article  PubMed  CAS  Google Scholar 

  10. Oyelese Y, Ananth CV (2010) Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol 53:147–156

    Article  PubMed  Google Scholar 

  11. Danish Society for Obstetrics and Gynaecology http://www.dsog.dk

  12. Milman N, Agger OA, Nielsen OJ (1991) Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo controlled study in 207 Danish women. Dan Med Bull 38:471–476

    PubMed  CAS  Google Scholar 

  13. Åkesson A, Bjellerup P, Berglund M, Bremme K, Vahter M (2002) Soluble transferrin receptor: longitudinal assessment from pregnancy to postlactation. Obstet Gynecol 99:260–266

    Article  PubMed  Google Scholar 

  14. World Health Organization. Iron deficiency anemia. Assessment, prevention and control. 2001;WHO/NHD/01.3

  15. Milman N, Bergholt T, Eriksen L, Byg K-E, Graudal N, Pedersen P, Hertz J (2005) iron prophylaxis during pregnancy—how much iron is needed? A randomised, controlled study of 20 to 80 mg ferrous iron daily to pregnant women. Acta Obstet Gynecol Scand 84:238–247

    PubMed  Google Scholar 

  16. Milman N (2006) Iron and pregnancy—a delicate balance. Ann Hematol 85:559–565

    Article  PubMed  CAS  Google Scholar 

  17. Bothwell TH (2000) Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 72:257S–264S

    PubMed  CAS  Google Scholar 

  18. Siimes MA, Vuori E, Kuitunen P (1979) Breast milk iron—a declining concentration during the course of lactation. Acta Paed Scand 68:29–31

    Article  CAS  Google Scholar 

  19. Pedersen AN, Fagt S, Groth MV, Christensen T, Biltoft-Jensen, Matthiessen J, et al. Dietary habits in Denmark 2003–2008. Main results: National Food Agency of Denmark. 2010

  20. Commission of the European Communities. Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food. Directorate General Industry 1993;31st series:180–181

  21. National Collaborating Centre for Women's & Children's Health. NICE Clinical Guideline 62—Antenatal Care; March 2008

  22. Social-og helsedirektoratet. Retningslinjer for svangerskapsomsorgen. www.shdir.no/publikasjoner Accessed December 2008

  23. Recommendations CDC (1998) to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 47:1–29

    Google Scholar 

  24. International Food information Council Foundation. Healthy eating during pregnancy. www.foodinsight.org Accessed January 2009

  25. www.altomkost.dk Accessed January 2010

  26. www.meraadet.dk Accessed March 2008

  27. Swedish Society for Obstetrics and Gynecology. Maternal health, sexual and reproductive health (Mödrahälsovård, sexuell och reproduktiv hälsa) 2008;rapport no. 59:47–48

  28. Trygg K, Lund-Larsen K, Sandstad B, Hoffman HJ, Jacobsen G, Bakketeig LS (1995) Do pregnant smokers eat differently from pregnant non-smokers? Paediatr Perinat Epidemiol 9:307–319

    Article  PubMed  CAS  Google Scholar 

  29. Nordic Council of Ministers. Nordic Nutrition Recommendations 2004. Copenhagen 2004

  30. Milman N, Byg K-E, Bergholt T, Eriksen L, Hvas A-M (2006) Body iron and individual iron prophylaxis in pregnancy—should the iron dose be adjusted according to serum ferritin? Ann Hematol 85:567–573

    Article  PubMed  CAS  Google Scholar 

  31. Milman N (2006) Iron prophylaxis in pregnancy—general or individual and in which dose? Ann Hematol 85:821–828

    Article  PubMed  CAS  Google Scholar 

  32. Breymann C, Honegger C, Holzgreve W, Surbek D. Diagnostik und Therapie der Anämie in der Schwangerschaft und postpartal. Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe. Expertenbrief 2007 no. 22

  33. Beris P, Maniatis A, on behalf of the NATA working group on intravenous iron therapy. Guidelines on intravenous iron supplementation in surgery and obstetrics/gynecology. Transfusion Alternatives in Transfusion Medicine 2007;9 Suppl 1:29

    Google Scholar 

  34. ACOG Practice Bulletin (2006) clinical management guidelines for obstetrician/gynecologists number 76, 2006: postpartum hemorrhage. Obstet Gynecol 108:1039–1047

    Article  Google Scholar 

  35. L Royal College of Obstetricians and Gynaecologist, Green top Guidelines, November 2009 http://www.rcog.org.uk/files/rcog-corp/Green-top52PostpartumHaemorrhage.pdf

  36. Rajan PV, Wing DA (2010) Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol 53:165–181

    Article  PubMed  Google Scholar 

  37. Russell RT. WHO guidelines for the management of postpartum haemorrhage and retained placenta. World Health Organization WHO Press, Geneva, Switzerland, 2009, ISBN 978-92-4-159851-4

  38. Dar S, Vardi IS, Holcberg G, Reuveni H, Yerushalmi R, Katz M, Sheiner E (2006) Do we need routine complete blood count following vaginal delivery? Int J Fertil Womens Med 51:270–273

    PubMed  Google Scholar 

  39. Recommendation to prevent and control iron deficiency in the United States. MMWR Morb Mortal Wkly Rep 1998; 47(RR-3):13–25

    Google Scholar 

  40. Dodd JM, Dare MR, Middleton P. Treatment for women with postpartum iron deficiency anemia. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD004222. DOI: 10.1002/14651858.CD004222.pub2

  41. Skikne B, Baynes RD (1994) Iron absorption. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds) iron metabolism in health and disease. Saunders, London, pp 151–187

    Google Scholar 

  42. Milman N, Graudal N, Nielsen OJ, Agger AO (1997) Serum erythropoietin during normal pregnancy: relationship to hemoglobin and iron status markers and impact of iron supplementation in a longitudinal, placebo-controlled study on 118 women. Int J Hematol 66:159–168

    Article  PubMed  CAS  Google Scholar 

  43. Krafft A, Breymann C (2011) Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study. J Obstet Gynaecol Res 37:119–124

    Article  PubMed  CAS  Google Scholar 

  44. Nielsen JB, Ikkala E, Sölvell L, Björn-Rasmussen E, Ekenved G (1976) Absorption of iron from slow-release and rapidly-disintegrating tablets—a comparative study in normal subjects, blood donors and subjects with iron deficiency anemia. Scand J Haematol Suppl 28:89–97

    PubMed  CAS  Google Scholar 

  45. Venofer®. Summary of Product Characteristics www.medicines.org.uk Accessed February 6th 2011

  46. CosmoFer®. Summary of Product Characteristics www.medicines.org.uk Accessed February 6th 2011

  47. Ferinject®. Summary of Product Characteristics www.medicines.org.uk Accessed February 6th 2011

  48. Lyseng-Williamson KA, Keating GM (2009) Ferric carboxymaltose: a review of its use in iron-deficiency anemia. Drugs 69:739–756

    Article  PubMed  CAS  Google Scholar 

  49. Monofer®. Summary of Product Characteristics www.medicines.org.uk Accessed February 6th 2011

  50. al-Momen AK, al-Meshari A, al-Nuaim L, Saddique A, Abotalib Z, Khashogji T et al (1996) Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 69:121–124

    Article  PubMed  CAS  Google Scholar 

  51. al-Ragip A, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A (2005) Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol 106:1335–1340

    Article  CAS  Google Scholar 

  52. Hallak M, Sharon A, Duikman R, Auslender R, Abramovici H (1997) Supplementation iron intravenously in pregnancy. A way to avoid blood transfusions. J Reprod Med 42:99–103

    PubMed  CAS  Google Scholar 

  53. Breymann C, Visca E, Huch R, Huch A (2001) Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. Am J Obstet Gynecol 184:662–667

    Article  PubMed  CAS  Google Scholar 

  54. Bashiri A, Burstein E, Sheiner E, Mazor M (2003) Anemia during pregnancy and treatment with intravenous iron: review of the literature. Eur J Obstet Gynecol Reprod Biol 110:2–7

    Article  PubMed  CAS  Google Scholar 

  55. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A (2007) Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia. A randomised controlled trial. Obstet Gynecol 110:267–278

    Article  PubMed  Google Scholar 

  56. Breymann C, Richter C, Hüttner C, Huch R, Huch A (2000) Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anemia and blunted erythropoiesis. Eur J Clin Invest 30:154–161

    Article  PubMed  CAS  Google Scholar 

  57. Bhandal N, Russell R (2006) Intravenous versus oral iron therapy for postpartum anemia. BJOG 113:1248–1252

    Article  PubMed  CAS  Google Scholar 

  58. Giannoulis C, Daniilidis A, Tantanasis T, Dinas K, Tzafettas J (2009) Intravenous administration of iron sucrose for treating anemia in postpartum women. Hippokratia 13:38–40

    PubMed  CAS  Google Scholar 

  59. Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R (2008) Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obst Gynecol 199:435e1–435e7

    Article  Google Scholar 

  60. Westad S, Backe B, Salvesen KÅ, Nakling J, Økland I, Borthen I et al (2008) A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia. Acta Obstet Gynecol Scand 87:916–923

    Article  PubMed  CAS  Google Scholar 

  61. Ganzoni AM (1972) Totalinfusion von Ferri-Kohlenhydrat-Komplexen (Total infusion of ferri-carbohydrate complexes). Blut 25:349–351

    Article  PubMed  CAS  Google Scholar 

  62. Swedish Dental and Pharmaceutical Benefits Agency http://www.tlv.se/in-english Accessed February 6th 2011

  63. Kotto-Kome AC, Calhoun DA, Montenegro R, Sosa R, Maldonado L, Christensen RD (2004) Effect of administering recombinant erythropoietin to women with postpartum anemia: a meta-analysis. J Perinatol 24:11–15

    Article  PubMed  CAS  Google Scholar 

  64. Wågström E, Åkesson A, Van Rooijen M, Larson B, Bremme K (2007) Erythropoietin and intravenous iron therapy in postpartum anemia. Acta Obstet Gynecol Scand 86:957–962

    Article  PubMed  Google Scholar 

  65. Lebrecth A, Häberlin f, Eberhard J (1995) Anämie im Wochenbett; parenterale Eisensubstitution macht Erythropoietin-Therapie entberlich (Postpartum anaemia; intravenous iron supplementation renders therapy with rhEPO redundant). Geburtshilfe Frauenheilkd 55:167–170

    Article  Google Scholar 

  66. Breymann c, Zimmermann R, Huch A (1996) Use of recombinant erythropoietin in combination with parenteral iron in the treatment of postpartum anemia. Eur J Clin Invest 26:123–130

    Article  PubMed  CAS  Google Scholar 

  67. Macrydimas G, Lolis G, Lialios G, Tsiara S, Georgiou I, Bourantas KL (1998) Recombinant human erythropoietin treatment of postpartum anemia. Preliminary results. Eur J Obstet Gynecol Reprod Biol 81:27–31

    Article  Google Scholar 

  68. Gyamfi C, Berkowitz RL (2007) Management of pregnancy in a Jehova's Witness. Obs Gynecol Clin N Am 34:357–365

    Article  Google Scholar 

  69. Bunn HF (2009) End run about Epo. New Engl J Med 361:1901–1903

    Article  PubMed  CAS  Google Scholar 

  70. Roberts CL, Ford JB, Thomson JF, Morris JM (2008) Population rates of hemorrhage and transfusions among obstetric patients in NSW: a short communication. Aust N Z J Obstet Gynaecol 48:481–484

    Article  PubMed  Google Scholar 

  71. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B (2008) Prevalence and risk factors of severe obstetric hemorrhage. BJOG 115:1265–1272

    Article  PubMed  CAS  Google Scholar 

  72. Rouse DJ, MacPherson C, Landon M, Varner MW, Leveno KJ, Moawad AH et al (2006) Blood transfusion and cesarean delivery. Obstet Gynecol 108:891–897

    Article  PubMed  Google Scholar 

  73. Fuller AJ, Bucklin BA (2010) Blood product replacement for postpartum hemorrhage. Clin Obstet Gynecol 53:196–208

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

The author has given educational lectures for Abbott International, Pharmacosmos Ltd., and Vifor Pharma Ltd.

Author information

Authors and Affiliations

  1. Departments of Clinical Biochemistry and Obstetrics, Næstved Hospital, Næstved, Denmark

    Nils Milman

  2. Lindevangen 87B, 2830, Virum, Denmark

    Nils Milman

Authors
  1. Nils Milman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nils Milman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milman, N. Postpartum anemia II: prevention and treatment. Ann Hematol 91, 143–154 (2012). https://doi.org/10.1007/s00277-011-1381-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-011-1381-2

Keywords

Search

Navigation